Proton therapy

Varian Announces New Addition to FlashForward Consortium

Monday, May 18, 2020 - 1:15pm

Now including 20 members, representing nine countries, the Consortiumis focused on preclinical research, clinical implementation, and advocacy efforts of FLASH therapy.

Key Points: 
  • Now including 20 members, representing nine countries, the Consortiumis focused on preclinical research, clinical implementation, and advocacy efforts of FLASH therapy.
  • Varian is installing a Varian ProBeam Compact system equipped with a 360-degree gantry and integrated cone beam CT at Proton Therapy Pte., Ltd.'s site in Singapore.
  • "We are proud to welcome Proton Therapy Pte., Ltd. to the FlashForward Consortium," said Kolleen Kennedy, chief growth officer and president of Proton Therapy Solutions, Varian.
  • "Representing our first member from Southeast Asia, they are a significant new addition to the Consortium.

Hitachi's First Proton Therapy System in Europe Opens at Clinica Universidad de Navarra in Spain

Friday, May 8, 2020 - 2:22am

Clinica Universidad de Navarra is the first hospital which Hitachi has delivered the whole proton therapy system in Europe.

Key Points: 
  • Clinica Universidad de Navarra is the first hospital which Hitachi has delivered the whole proton therapy system in Europe.
  • The proton therapy system installed at Clinica Universidad de Navarra is equipped with state-of-the-art technology including spot scanning technology that sends a therapeutic proton beam precisely conforming to the shape of the target tumor.
  • And it has a 360degree rotating gantry treatment room with cone beam CT(1) and Real-time image Gated Proton Therapy (RGPT)(2) capability.
  • Clinica Universidad de Navarra, based in Navarra and Madrid, Spain, is a world-class private hospital focusing on medical research, education and clinical care.

The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) - ResearchAndMarkets.com

Thursday, May 14, 2020 - 3:25pm

The number of companies involved in cell therapy has increased remarkably during the past few years.

Key Points: 
  • The number of companies involved in cell therapy has increased remarkably during the past few years.
  • Profiles of 72 academic institutions in the US involved in cell therapy are also included in part II along with their commercial collaborations.
  • Cell therapy technologies overlap with those of gene therapy, cancer vaccines, drug delivery, tissue engineering and regenerative medicine.
  • Safety is an essential consideration of any new therapy and regulations for cell therapy are those for biological preparations.

Novel Coronavirus' Impact on Radiation Therapy Markets, 2020-2024 - Slowdown in Emerging Markets, Change in Organic Traffic, Impact on Radiation Therapy, Risk Factors for Severe Adverse Events

Wednesday, May 13, 2020 - 9:00pm

The Global Radiation Therapy Market is expected to reach US$10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.

Key Points: 
  • The Global Radiation Therapy Market is expected to reach US$10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
  • Factors such as surging incidence of cancer cases, rising healthcare expenditure, upsurge in economic growth, growing ageing population and expanding urbanization are expected to drive the global radiation therapy market.
  • The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type.
  • Depending upon the type, the global external beam radiation therapy market can be categorized into following categories: Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Tomotherapy, Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy and Proton Therapy.

Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2020-2024) - ResearchAndMarkets.com

Tuesday, May 12, 2020 - 3:09pm

The "Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Radiation Therapy Market is expected to reach US$10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
  • The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type.
  • Depending upon the type, the global external beam radiation therapy market can be categorized into following categories: Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Tomotherapy, Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy and Proton Therapy.

American Shared Hospital Services Reports First Quarter 2020 Results

Monday, May 11, 2020 - 1:00pm

SAN FRANCISCO, CA, May 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the first quarter ended March 31, 2020.

Key Points: 
  • SAN FRANCISCO, CA, May 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the first quarter ended March 31, 2020.
  • Net loss in the first quarter was $135,000 compared to net income of $270,000 for the first quarter of 2019.
  • Adjusted EBITDA, a non-GAAP financial measure, was $1,822,000 for the first quarter of 2020, compared to $2,710,000 for the first quarter of 2019.
  • About American Shared Hospital Services (NYSE American: AMS)
    American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services.AMS is the world leader in providing Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations, and trigeminal neuralgia (facial pain).The Company also offers proton therapy, and the latest IGRT, IMRT and MR/LINAC systems.

Mevion Medical Systems Signs Agreement to Bring Compact Proton Therapy to Texas

Monday, May 11, 2020 - 11:30am

Mevion Medical Systems announced today that it has signed a letter of intent to provide the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) to an independent service provider in Texas.

Key Points: 
  • Mevion Medical Systems announced today that it has signed a letter of intent to provide the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) to an independent service provider in Texas.
  • It will be the first compact proton therapy center in Texas.
  • Mevions industry-leading compact proton therapy systems have reduced the enormous expenditures and space requirements needed by other systems, allowing more cancer centers the ability to add proton therapy to their treatment offerings.
  • Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients.

Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Monday, May 4, 2020 - 8:00pm

The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type.

Key Points: 
  • The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type.
  • Depending upon the type, the global external beam radiation therapy market can be categorized into following categories: Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Tomotherapy, Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy and Proton Therapy.
  • Whereas, on the basis of devices, the global external beam radiation therapy market can be segmented into three categories, named as, LINAC (Linear Accelerators), proton beam therapy devices and compact advanced therapy devices.
  • The report provides a comprehensive analysis of the global radiation therapy market segmented on the basis of type.

MEVION S250i Proton Therapy System Receives Approval from Health Canada

Thursday, April 23, 2020 - 11:30am

Mevion Medical Systems announced today that the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) has received a Medical Device License from Health Canada, opening the door for commercial sales in Canada.

Key Points: 
  • Mevion Medical Systems announced today that the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) has received a Medical Device License from Health Canada, opening the door for commercial sales in Canada.
  • The MEVION S250i is the only proton therapy system approved for use in Canada.
  • Mevion was the first company to innovate this new approach to proton therapy and have more systems installed and treating patients than any other compact proton therapy manufacturer in the US.
  • Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients.

Danbury Proton Selects Mevion To Equip New Treatment Center

Tuesday, April 21, 2020 - 11:30am

Mevion Medical Systems announced today that it has signed an agreement with Danbury Proton to purchase the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) to equip their new center in Danbury, CT. Danbury Proton has recently published a notice of intent to submit a Certificate of Need (CON) to the Connecticut State Office of Health Strategy for a new state-of-the-art center that is slated to employ over 30 full-time employees.

Key Points: 
  • Mevion Medical Systems announced today that it has signed an agreement with Danbury Proton to purchase the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) to equip their new center in Danbury, CT. Danbury Proton has recently published a notice of intent to submit a Certificate of Need (CON) to the Connecticut State Office of Health Strategy for a new state-of-the-art center that is slated to employ over 30 full-time employees.
  • View the full release here: https://www.businesswire.com/news/home/20200421005152/en/
    Rendering of the future Danbury Proton center.
  • (Photo: Business Wire)
    The MEVION S250i with HYPERSCAN was the logical choice to equip our new center, said Stephen Courtney, managing director of Danbury Proton.
  • Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients.